BlackRock Health Sciences Term Trust (NYSE:BMEZ) Major Shareholder Saba Capital Management, L.P. Acquires 2,006 Shares

BlackRock Health Sciences Term Trust (NYSE:BMEZ) major shareholder Saba Capital Management, L.P. acquired 2,006 shares of the business’s stock in a transaction dated Monday, September 23rd. The stock was acquired at an average cost of 15.98 per share, for a total transaction of 32,055.88. Following the transaction, the insider now owns 20,603,574 shares of the company’s stock, valued at 329,245,112.52. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Large shareholders that own at least 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Saba Capital Management, L.P. also recently made the following trade(s):

• On Thursday, September 19th, Saba Capital Management, L.P. purchased 15,455 shares of BlackRock Health Sciences Term Trust stock. The stock was acquired at an average price of 16.14 per share, for a total transaction of 249,443.70.
• On Tuesday, September 17th, Saba Capital Management, L.P. acquired 27,148 shares of BlackRock Health Sciences Term Trust stock. The stock was acquired at an average price of 15.93 per share, with a total value of 432,467.64.

BlackRock Health Sciences Term Trust Stock Performance

Shares of BMEZ stock traded down 0.19 during trading hours on Tuesday, hitting 15.83. 178,300 shares of the company were exchanged, compared to its average volume of 276,629. The company has a 50 day simple moving average of 15.85 and a two-hundred day simple moving average of 15.55. BlackRock Health Sciences Term Trust has a fifty-two week low of 12.93 and a fifty-two week high of 16.59.

BlackRock Health Sciences Term Trust Dividend Announcement

The company also recently disclosed a monthly dividend, which will be paid on Thursday, October 31st. Investors of record on Tuesday, October 15th will be paid a $0.176 dividend. The ex-dividend date of this dividend is Tuesday, October 15th. This represents a $2.11 annualized dividend and a yield of 13.34%.

Institutional Investors Weigh In On BlackRock Health Sciences Term Trust

Several institutional investors have recently made changes to their positions in the stock. Benjamin F. Edwards & Company Inc. boosted its position in BlackRock Health Sciences Term Trust by 21.7% during the first quarter. Benjamin F. Edwards & Company Inc. now owns 5,830 shares of the company’s stock valued at $96,000 after buying an additional 1,038 shares during the period. Register Financial Advisors LLC increased its position in shares of BlackRock Health Sciences Term Trust by 5,365.6% during the second quarter. Register Financial Advisors LLC now owns 6,832 shares of the company’s stock valued at $105,000 after acquiring an additional 6,707 shares in the last quarter. Shaker Financial Services LLC bought a new stake in BlackRock Health Sciences Term Trust in the 2nd quarter worth approximately $184,000. Pine Valley Investments Ltd Liability Co grew its position in BlackRock Health Sciences Term Trust by 6.7% in the 4th quarter. Pine Valley Investments Ltd Liability Co now owns 13,088 shares of the company’s stock worth $192,000 after purchasing an additional 822 shares during the period. Finally, Comerica Bank boosted its stake in shares of BlackRock Health Sciences Term Trust by 31.1% during the 1st quarter. Comerica Bank now owns 15,469 shares of the company’s stock worth $254,000 after acquiring an additional 3,671 shares during the last quarter.

BlackRock Health Sciences Term Trust Company Profile

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.